GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Change In Inventory

Hard to Treat Diseases (Hard to Treat Diseases) Change In Inventory : $0.00 Mil (TTM As of . 20)


View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases Change In Inventory?

Hard to Treat Diseases's change in inventory for the quarter that ended in . 20 was $0.00 Mil. It means Hard to Treat Diseases's inventory stayed the same from . 20 to . 20 .

Hard to Treat Diseases's change in inventory for the fiscal year that ended in . 20 was $0.00 Mil. It means Hard to Treat Diseases's inventory stayed the same from . 20 to . 20 .

Hard to Treat Diseases's Total Inventories for the quarter that ended in . 20 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Hard to Treat Diseases Change In Inventory Historical Data

The historical data trend for Hard to Treat Diseases's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases Change In Inventory Chart

Hard to Treat Diseases Annual Data
Trend
Change In Inventory

Hard to Treat Diseases Quarterly Data
Change In Inventory

Hard to Treat Diseases Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hard to Treat Diseases  (OTCPK:HTDS) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Hard to Treat Diseases's Days Inventory for the quarter that ended in is calculated as:

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Hard to Treat Diseases's Inventory Turnover for the quarter that ended in . 20 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Hard to Treat Diseases's Inventory to Revenue for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hard to Treat Diseases Change In Inventory Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Hard to Treat Diseases (Hard to Treat Diseases) Business Description

Traded in Other Exchanges
N/A
Address
2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762
Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases (Hard to Treat Diseases) Headlines

No Headlines